TMO
Thermo Fisher Scientific Inc.
Stock
$675.05−4.56 (−0.67%)Close Sep 30, 2026
| Selling, general and administrative (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $9.0B | +6.0% | 4.7% | 6.6% |
| Selling, general and administrative (TTM) | $9.0B |
|---|---|
| YoY | +6.0% |
| 5-year CAGR | 4.7% |
| 10-year CAGR | 6.6% |
Selling, general and administrative
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $8.7B | +1.6% |
| 2024 | $8.6B | +1.8% |
| 2023 | $8.4B | −6.1% |
| 2022 | $9.0B | +12.3% |
| 2021 | $8.0B | +15.5% |
| 2020 | $6.9B | +12.8% |
| 2019 | $6.1B | +1.4% |
| 2018 | $6.1B | +10.0% |
| 2017 | $5.5B | +10.7% |
| 2016 | $5.0B | +7.8% |
| 2015 | $4.6B | −5.8% |
| 2014 | $4.9B | +42.1% |
| 2013 | $3.4B | +2.7% |
| 2012 | $3.4B | +8.0% |
| 2011 | $3.1B | +13.8% |
| 2010 | $2.7B | +5.2% |
| 2009 | $2.6B | −3.7% |
| 2008 | $2.7B | +5.6% |
| 2007 | $2.5B | — |